We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
ADLM 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Tactus AI Unveils Humanoid Assistant for Clinical Laboratory Bench Work

By LabMedica International staff writers
Posted on 28 Jul 2026

Clinical laboratories continue to face sustained staffing shortages even as test volumes and complexity rise. Many facilities have automated instruments but lack enough qualified bench operators to keep them running across extended shifts. To help address this gap, Tactus AI has unveiled a new humanoid lab assistant at ADLM 2026 that works directly at the bench to run existing analyzers under a laboratory’s validated standard operating procedures.

Elsie by Tactus AI is an autonomous two-armed assistant is built for clinical bench work and is being demonstrated on the ADLM Clinical Lab Expo floor. The system is paired with Tactus Lab Orchestration software to plan and execute multi‑step protocols across robots, instruments, and staff. Elsie is positioned to support laboratories that want to increase instrument uptime without retooling benches or replacing analyzers.


Image: Elsie by Tactus is designed to work alongside lab staff, operate existing instruments, follow validated SOPs, and go live only after the lab’s QA sign-off (Photo courtesy of Tactus AI)
Image: Elsie by Tactus is designed to work alongside lab staff, operate existing instruments, follow validated SOPs, and go live only after the lab’s QA sign-off (Photo courtesy of Tactus AI)

Elsie combines tactile and force sensing with depth perception and machine vision, coordinated by a proprietary learning software suite. The platform’s skill library holds validated capabilities, each certified against a customer’s standard operating procedures (SOPs) before deployment. Across its skills, Elsie is designed to monitor instruments and flag exceptions, move samples and consumables, run tests to validated SOPs, clear first‑line faults, perform routine cleaning and calibration tasks, and log all actions to the orchestration platform.

Implementation is structured around customer quality oversight. Tactus builds a high‑fidelity digital twin of the bench so Elsie’s policies can be trained and stress‑tested across hundreds of simulated runs prior to any live samples. Each skill is then validated on site against acceptance criteria, and nothing runs live until the laboratory’s own quality team approves it. The platform operates within enterprise security and privacy standards, including ISO 27001, SOC 2 Type II (July 2026), and compliance with HIPAA and GDPR. The system supports laboratory operations and is not offered as a diagnostic device.

Tactus is selecting three to five launch laboratories in 2026, with initial pilots at U.S. academic medical centers. Engagements begin with a four‑domain readiness review—physical site, instruments, workflow, and data systems—followed by a Robot‑Readiness Assessment delivered within 30 days that outlines gaps, a skill roadmap, and pilot scope. Elsie is on view at ADLM 2026 Booth 2616 in Anaheim through July 30.

“Labs aren’t short on automation. They’re short on hands. Most labs own instruments that could run far more hours than they do. What’s missing is a trained operator to keep them running. That’s what we built Elsie to do, and she does it on the bench using the SOPs a lab already has, instead of asking the lab to rebuild around a robot,” said Michael Quick, Chief Commercial Officer of Tactus AI.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Electrolyte Analyzer
BKE-B

Latest ADLM 2026 News

Roche Presents Intelligent Lab Solutions and High-Precision Instruments at ADLM 2026
27 Jul 2026  |   ADLM 2026

ADLM 2026 Explores Diabetes Milestones, Space Diagnostics, Alzheimer’s–Down Syndrome Links, and Cancer Advances
27 Jul 2026  |   ADLM 2026

Cepheid Unveils Third-Generation GeneXpert System at ADLM 2026
27 Jul 2026  |   ADLM 2026



PURITAN MEDICAL